Welcome to the Hope Bio Blog

By Jan Shultis, Ph.D. Earlier this season, we shared a three-part series on how and why Hope Bio’s location in the United States (U.S.), in Texas, near Houston, and in Sugar Land directly affects your access to our cellular therapeutics. If you missed it, those entries are found at the links below: Part One: Good Manufacturing Practice (GMP): What it means, why it matters Part Two: Texan, Houstonian: how and why Hope’s location shapes our work and your access Part Three: Up

By Jan Shultis, Ph.D. America celebrated her 250th anniversary of independence this year. As Hope Bio marked the occasion with family, friends, and community, the flags waving and fireworks in the air served as a reminder of how grateful we are to be in America (specifically in Texas, and in Sugar Land (west of Houston), but more on that in the linked discussions). Pride in the red, white, and blue is more than emotive sentiment. Cellular therapeutics are produced all over

A conversation about medical usefulness, money, and health in individual families By Jan Shultis, Ph.D. Cord blood banking is the practice of preserving the blood found in a baby’s umbilical cord at birth, with the intention that the hematopoietic stem cells found in cord blood could one day be used to create stem cell treatments, should that newborn be diagnosed with a blood-based disease or condition. Umbilical cord blood stem cells have been used in treatment since the fir